Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Phentermine Serotonin Reuptake transporter Satiety Action Pathway
Homo sapiens
Drug Action Pathway
Phentermine is an amine anorectic agent used in weight reduction in cases of exogenous obesity as an adjunct or alone. It is chemically related to amphetamine. It is thought that the primary way phentermine works is by inducing a reduction in appetite, potentially through the elevation of leptin levels. However, it's believed that there are likely additional mechanisms to help reduce the weight. This molecule also acts by releasing more noradrenaline from the presynaptic vesicles situated in the lateral hypothalamus. This elevation in this hormone's concentration within the synaptic cleft triggers the activation of beta2-adrenergic receptors. This drug also impacts dopamine levels, along with its consequential influence on serotonin. These combined effects lead to a continuous fight-or-flight response within the body, diminishing hunger signals. Phentermine inhibits the sodium-dependent noradrenaline transporter, the sodium-dependent serotonin transporter, and the sodium-dependent dopamine transporter. This drug is administered as an oral capsule.
References
Phentermine Serotonin Reuptake transporter Satiety Pathway References
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Johnson DB, Quick J: Topiramate and Phentermine.
Pubmed: 29489234
Ryder JR, Kaizer A, Rudser KD, Gross A, Kelly AS, Fox CK: Effect of phentermine on weight reduction in a pediatric weight management clinic. Int J Obes (Lond). 2017 Jan;41(1):90-93. doi: 10.1038/ijo.2016.185. Epub 2016 Oct 24.
Pubmed: 27773937
Kiortsis DN: A review of the metabolic effects of controlled-release Phentermine/Topiramate. Hormones (Athens). 2013 Oct-Dec;12(4):507-16. doi: 10.14310/horm.2002.1438.
Pubmed: 24457398
Garvey WT: Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management. Expert Opin Drug Saf. 2013 Sep;12(5):741-56. doi: 10.1517/14740338.2013.806481. Epub 2013 Jun 6.
Pubmed: 23738843
Bersoux S, Byun TH, Chaliki SS, Poole KG: Pharmacotherapy for obesity: What you need to know. Cleve Clin J Med. 2017 Dec;84(12):951-958. doi: 10.3949/ccjm.84a.16094.
Pubmed: 29244650
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings